1-4 of 4
Tanios Bekaii-Saab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities

Erin E. Talbert, Jennifer Yang, Thomas A. Mace, Matthew R. Farren, Alton B. Farris, Gregory S. Young, Omar Elnaggar, Zheng Che, Cynthia D. Timmers, Priyani Rajasekera, Jennifer M. Maskarinec, Mark Bloomston, Tanios Bekaii-Saab, Denis C. Guttridge, Gregory B. Lesinski
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (2): 344–356.
https://doi.org/10.1158/1535-7163.MCT-16-0337
Published: 02 February 2017
View article titled, Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities
Open the PDF for Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities in another window
Includes: Supplementary data
Journal Articles

Abstract A76: Enhancement of cetuximab-induced antibody-dependent cellular cytotoxicity with lenalidomide in advanced solid tumors: A Phase I trial.

Erin M. Bertino, Jeffrey S. Rose, Christina Wu, Tanios Bekaii-Saab, Panayiotis S. Savvides, Richard M. Goldberg, Miguel Villalona, Gerard Lozanski, William Carson, Michael Grever, Gregory Otterson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A76.
https://doi.org/10.1158/1535-7163.TARG-13-A76
Published: 01 November 2013
View article titled, Abstract A76: Enhancement of cetuximab-induced antibody-dependent cellular cytotoxicity with lenalidomide in advanced solid tumors: A Phase I trial.
Journal Articles

Abstract A99: Phase I trial of veliparib or mitomycin C + veliparib in pts with Fanconi anemia pathway (FA) repair defects.

Miguel A. Villalona-Calero, Wenrui Duan, Weiqiang Zhao, Li Gao, Jennifer Thurmond, Marino Leon, Konstantin Shilo, Tricia De Fiore, Judith A. Westman, Jay Ji, Yiping Zhang, John Marshall, Jeff Rose, Tanios Bekaii-Saab, Alice Chen, Gregory Otterson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A99.
https://doi.org/10.1158/1535-7163.TARG-11-A99
Published: 12 November 2011
View article titled, Abstract A99: Phase I trial of veliparib or mitomycin C + veliparib in pts with Fanconi anemia pathway (FA) repair defects.
Journal Articles

Abstract C221: EZN‐2208, a novel anticancer agent, in patients (pts) with advanced malignancies: A phase 1 dose‐escalation study

Amita Patnaik, Kyriakos P. Papadopoulos, Muralidhar Beeram, Debbie Kee, Anthony W. Tolcher, Larry J. Schaaf, Sanaa Tahiri, Tanios Bekaii‐Saab, Aby Buchbinder
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C221.
https://doi.org/10.1158/1535-7163.TARG-09-C221
Published: 10 December 2009
View article titled, Abstract C221: EZN‐2208, a novel anticancer agent, in patients (pts) with advanced malignancies: A phase 1 dose‐escalation study